Company intelligence / Profile preview

PKA SoftTouch

Lakeview, Nova Scotia, Canada

Ownership: Private
Employees: ~10
Development stage: Other

Overview

PKA SoftTouch is a medical device company specializing in the development of a revolutionary, painless microneedle injection system. The company's flagship product, the PKA Micro-Needle, is designed to deliver life-saving medications, such as insulin, into the skin's epidermal layer where there are no pain receptors. This technology aims to replace traditional syringe injections and pens, offering a more comfortable and user-friendly alternative for patients with chronic conditions like diabetes. PKA SoftTouch is currently advancing its device through clinical trials to demonstrate efficacy and safety for various therapeutic applications, including vaccines and other biologics.

Therapeutic areas: Infectious DiseasesEndocrinology
Modalities: DeviceMicroneedle
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on PKA SoftTouch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PKA SoftTouch.

Explore the full profile